Oyster Point Pharma, Inc. Quarterly Revenues in USD from Q3 2021 to Q3 2022

Taxonomy & unit: us-gaap: USD
Description: Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary: Oyster Point Pharma, Inc. quarterly Revenues history and growth rate from Q3 2021 to Q3 2022.
Oyster Point Pharma, Inc. Revenues for the quarter ending September 30, 2022 was $5.59M, a 68.8% decline year-over-year.

Revenues, Quarterly (USD)

Revenues, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2022		$5.59M	-$12.4M	-68.8%	Jul 1, 2022	Sep 30, 2022	10-Q	2022-11-10
Q3 2021		$17.9M			Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.